Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union – Biogen | Investor Relations

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union  Biogen | Investor Relations



Source link : https://news.google.com/rss/articles/CBMie2h0dHBzOi8vaW52ZXN0b3JzLmJpb2dlbi5jb20vbmV3cy1yZWxlYXNlcy9uZXdzLXJlbGVhc2UtZGV0YWlscy91cGRhdGUtcmVndWxhdG9yeS1yZXZpZXctbGVjYW5lbWFiLWVhcmx5LWFsemhlaW1lcnMtZGlzZWFzZdIBAA?oc=5

Author :

Publish date : 2024-07-26 11:23:25

Copyright for syndicated content belongs to the linked Source.